Kathleen M. Giacomini is a professor of bioengineering and therapeutic sciences at the University of California, San Francisco. Her work focuses on how genetics affects the efficacy of drugs.[1] She is also the co-director UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation for the department of Bioengineering at the University of California, San Francisco.
Kathleen M. Giacomini | |
|---|---|
| Education | University at Buffalo |
| Honors | Scheele Award (2011) |
Giacomini has organized Health Care conferences in the San Francisco Bay Area [2]
Education edit
Giacomini earned her doctorate in pharmaceutics from the University at Buffalo. From 1979 to 81, Giacomini was a post-doctoral fellow in clinical pharmacology at Stanford University.[3]
Career edit
In 1998, Giacomini was named chair of the department of biopharmaceutical sciences at the University of California San Francisco.[4] In 1999, Giacomini became the first woman honored as Pharmaceutical Scientist of the Year by the International Pharmaceutical Federation.[5] In 2000, Giacomini organized the Pharmacogenomics of Membrane Transporters (PMT) Project at the University of California, San Francisco.[6] In 2005, while serving as vice chair of the Pharmacogenetics Research Network, Giacomini was awarded the Paul Dawson Biotechnology Award by the American Association of Colleges of Pharmacy.[4]
In 2010, Giacomini received the Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy.[7] The following year she was awarded the Scheele Award for her work on the pharmacogenetics of drug transporters.[8] In 2014, Giacomini became the co-director UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation for the department of Bioengineering.[9][10]
In 2018, Giacomini was awarded the Bill Heller Mentor of the Year Award by the American Foundation for Pharmaceutical Education[11] and the Volwiler Research Award.[12]
References edit
- ^ "2016 NIH Funding: A Look at Top Recipients and Their Research". University of California San Francisco. Retrieved 4 April 2019.
- ^ "Federal shutdown cancels conference aimed at health care cooperation". Biz Journals. Retrieved 4 April 2019.
- ^ Suzanne Chamberlain (March 29, 2002). "Noted Researcher to Speak on Drugs and Genes in the First Gerhard Levy Distinguished Lecture". buffalo.edu. Retrieved April 5, 2019.
- ^ a b "Giacomini Receives Dawson Award". pharmacy.ucsf.edu. July 19, 2005. Retrieved April 5, 2019.
- ^ "UCSF professor receives Pharmaceutical Scientist of the Year Award". eurekalert.org. September 6, 1999. Retrieved April 5, 2019.
- ^ "Giacomini, Haines, Johnson, and Kane to Receive ACCP Honors". accp.com. Retrieved April 5, 2019.
- ^ "Giacomini to receive Therapeutic Frontiers Lecture Award". pharmacy.ucsf.edu. October 14, 2010. Retrieved April 5, 2019.
- ^ "The Scheele Award 2011 to Professor Kathleen M. Giacomini for her pioneering work on the pharmacogenetics of drug transporters". mynewsdesk.com. January 11, 2011. Retrieved April 5, 2019.
- ^ Barry, Fiona (May 21, 2014). "US FDA founds regulatory science centre with UCSF and Stanford". .in-pharmatechnologist.com. Retrieved April 5, 2019.
- ^ Ron Leuty (May 5, 2014). "Stanford, UCSF target better drug development in new FDA partnership". bizjournals.com. Retrieved April 5, 2019.
- ^ Burningham, Grant (September 17, 2018). "Giacomini receives Bill Heller Mentor of the Year Award". pharmacy.ucsf.edu. Retrieved April 5, 2019.
- ^ Burningham, Grant (April 16, 2018). "Giacomini named 2018 Volwiler Research Award recipient". pharmacy.ucsf.edu. Retrieved April 5, 2019.